Source:http://linkedlifedata.com/resource/pubmed/id/17168812
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-12-15
|
pubmed:abstractText |
Tumor Associated Carbohydrate Antigens (TACAs) constitute powerful tools as tumor markers and as targets for anticancer immunotherapy. In this review, methods of production of glycopeptide-based vaccines, as well as results of preclinical and clinical studies in cancer patients are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1389-5575
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1357-73
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Carbohydrate antigens: synthesis aspects and immunological applications in cancer.
|
pubmed:affiliation |
CNRS, URA2128, Unité de Chimie Organique, Paris, France. tfreire@pasteur.fr
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|